Kimberlee C. Drapkin, CFO and Treasurer at Jounce Therapeutics, Inc. (JNCE), sold 46,201 shares at $12.03 ($536K) on 2021-01-20, disclosed to the SEC on 2021-01-22.
Open-market sale of $536k JNCE by CFO and Treasurer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.03 | 10,000 | $100K | 18.7% |
| 2 | $12.03 | 16,201 | $195K | 36.4% |
| 3 | $12.03 | 16,201 | $195K | 36.4% |
| 4 | $12.00 | 3,799 | $46K | 8.5% |
| Total | $11.59 avg | 46,201 | $536K | 100% |
| Filing → |
| JNCE | SELL | 2021-01-11 | $40K | — | Filing → |
| JNCE | SELL | 2020-09-02 | $58K | — | Filing → |
| JNCE | SELL | 2020-08-18 | $10K | — | Filing → |